Wiley Bros. Aintree Capital, LLC Corcept Therapeutics Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,589 shares of CORT stock, worth $337,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,589
Previous 6,185
25.8%
Holding current value
$337,153
Previous $706,000
52.41%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
479Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$711 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$567 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$460 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$284 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...